The November elections surely won't end the nonstop, eight-year political war over the shape of the U.S. healthcare system. But the ballot results likely will determine whether the changes driven by the ACA continue in the same direction or the system returns to its previous, less-regulated form.
Houston-based Decisio Health developed the first FDA-approved web-based clinical platform and created easy-to-read displays that alert clinicians to problems as they emerge.
History buffs and infectious-disease experts have already drawn links between the rubella outbreak in the 1960s and the current spread of Zika. But drugmakers today face greater regulatory hurdles, and the federal government has yet to dedicate funding to address the Zika epidemic.
A federal mandate to use unique device identifiers offers an opportunity to reduce the risk of patients being harmed by products, but the UDI system, which is being implemented over the next four years by the Food and Drug Administration, means a lot of changes— especially for the...
Pharmaceutical giant AstraZeneca failed to block approval of generics for its best-selling cholesterol drug after a federal judge tossed out the company's request.
The heads of the CMS and the Food and Drug Administration want health insurance claims form templates to include unique device identifiers.
The Food and Drug Administration has approved the first fully absorbable stent used to treat coronary artery disease. But physicians are likely to keep using metallic stents until later generations of biodegradable stents are released and more data are gathered on trial patients.
Federal health officials have approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.
A hedge fund manager was found dead in an apparent suicide Monday less than a week after he was charged with insider trading based on tips he allegedly received from a former Food and Drug Administration official.
Drugmakers are making increased use of consumer coupons, which are designed to thwart the high copays used by pharmacy benefit managers and insurers to channel consumers to less-costly generic drugs.
McKesson Corp. may be weighing a separation of its information technology unit as it works to contain costs and refocus on its core drug distribution business, according to the Wall Street Journal.
Sean Conlon has been named managing director and head of a new healthcare initiative at Bank of the West's commercial banking group based in Los Angeles.